These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 14529727)

  • 61. Comparative role of neurotoxin-associated proteins in the structural stability and endopeptidase activity of botulinum neurotoxin complex types A and E.
    Kukreja RV; Singh BR
    Biochemistry; 2007 Dec; 46(49):14316-24. PubMed ID: 18004882
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Ideal Injection Points for Botulinum Neurotoxin for Pectoralis Minor Syndrome: A Cadaveric Study.
    Lee JH; Lee HJ; Yi KH; Lee KW; Gil YC; Kim HJ
    Toxins (Basel); 2023 Oct; 15(10):. PubMed ID: 37888634
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Complete DNA sequences of the botulinum neurotoxin complex of Clostridium botulinum type A-Hall (Allergan) strain.
    Zhang L; Lin WJ; Li S; Aoki KR
    Gene; 2003 Oct; 315():21-32. PubMed ID: 14557061
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Proconvulsant actions of intrahippocampal botulinum neurotoxin B in the rat.
    Bröer S; Zolkowska D; Gernert M; Rogawski MA
    Neuroscience; 2013 Nov; 252():253-61. PubMed ID: 23906638
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Muscle volume alterations in spastic muscles immediately following botulinum toxin type-A treatment in children with cerebral palsy.
    Williams SA; Reid S; Elliott C; Shipman P; Valentine J
    Dev Med Child Neurol; 2013 Sep; 55(9):813-20. PubMed ID: 23789782
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Separation of the components of type A botulinum neurotoxin complex by electrophoresis.
    Sharma SK; Ramzan MA; Singh BR
    Toxicon; 2003 Mar; 41(3):321-31. PubMed ID: 12565755
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Botulinum neurotoxin A injection for the treatment of epiphora with patent lacrymal ducts.
    Girard B; Piaton JM; Keller P; Nguyen TH
    J Fr Ophtalmol; 2018 Apr; 41(4):343-349. PubMed ID: 29681465
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Mapping of the synaptosome-binding regions on the heavy chain of botulinum neurotoxin A by synthetic overlapping peptides encompassing the entire chain.
    Maruta T; Dolimbek BZ; Aoki KR; Steward LE; Atassi MZ
    Protein J; 2004 Nov; 23(8):539-52. PubMed ID: 15648976
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinical duration of action of different botulinum toxin types in humans.
    Eleopra R; Rinaldo S; Montecucco C; Rossetto O; Devigili G
    Toxicon; 2020 May; 179():84-91. PubMed ID: 32184153
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Detection of the HA-33 protein in botulinum neurotoxin type G complex by mass spectrometry.
    Kalb SR; Baudys J; Barr JR
    BMC Microbiol; 2015 Oct; 15():227. PubMed ID: 26494251
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Histomorphometric Changes of the Masseter Muscle of Rats After a Single Injection of Botulinum Toxin Type A.
    Ramos DM; de Brito Silva R; De la Torre Canales G; Resende L; Esquisatto MAM; Moreira NCF; Ernberg M; Rizzatti-Barbosa CM
    Aesthetic Plast Surg; 2024 Mar; 48(5):1037-1044. PubMed ID: 37620565
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Use of botulinum neurotoxin for spasticity].
    Mukai Y; Kaji R
    Brain Nerve; 2008 Dec; 60(12):1421-6. PubMed ID: 19110753
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The Regions on the Light Chain of Botulinum Neurotoxin Type A Recognized by T Cells from Toxin-Treated Cervical Dystonia Patients. The Complete Human T-Cell Recognition Map of the Toxin Molecule.
    Oshima M; Deitiker P; Jankovic J; Atassi MZ
    Immunol Invest; 2018 Jan; 47(1):18-39. PubMed ID: 28891721
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The role of human serum albumin and neurotoxin associated proteins in the formulation of BoNT/A products.
    Kutschenko A; Bigalke H; Wegner F; Wohlfarth K
    Toxicon; 2019 Oct; 168():158-163. PubMed ID: 31323228
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparative Pharmacodynamics of Three Different Botulinum Toxin Type A Preparations following Repeated Intramuscular Administration in Mice.
    Byun J; Kwak S; Kwon JH; Shin M; Lee DK; Rhee CH; Kang WH; Oh JW; Cruz DJM
    Toxins (Basel); 2022 May; 14(6):. PubMed ID: 35737026
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [
    Mann T; Kurth J; Hawlitschka A; Stenzel J; Lindner T; Polei S; Hohn A; Krause BJ; Wree A
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29509680
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Intramuscular nerve distribution pattern of the adductor longus and gracilis muscles demonstrated with Sihler staining: guidance for botulinum toxin injection.
    Won SY; Rha DW; Kim HS; Jung SH; Park ES; Hu KS; Kim HJ
    Muscle Nerve; 2012 Jul; 46(1):80-5. PubMed ID: 22644785
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Exchanging the minimal cell binding fragments of tetanus neurotoxin in botulinum neurotoxin A and B impacts their toxicity at the neuromuscular junction and central neurons.
    Höltje M; Schulze S; Strotmeier J; Mahrhold S; Richter K; Binz T; Bigalke H; Ahnert-Hilger G; Rummel A
    Toxicon; 2013 Dec; 75():108-21. PubMed ID: 23817019
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Functional impact of different muscle localization techniques for Botulinum neurotoxin A injections in clinical routine management of post-stroke spasticity.
    Zeuner KE; Knutzen A; Kühl C; Möller B; Hellriegel H; Margraf NG; Deuschl G; Stolze H
    Brain Inj; 2017; 31(1):75-82. PubMed ID: 27880052
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A pharmacodynamic comparison study of different botulinum toxin type A preparations.
    Kim SB; Ban B; Jung KS; Yang GH
    Dermatol Surg; 2013 Jan; 39(1 Pt 2):150-4. PubMed ID: 23301818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.